763502000: Product containing acalabrutinib (medicinal product)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing transferase inhibitor (product)\Phosphotransferase inhibitor-containing product\Protein kinase inhibitor-containing product\Protein-tyrosine kinase inhibitor-containing product\Product containing non-specific protein-tyrosine kinase inhibitor (product)\Acalabrutinib-containing product

\Medicinal product categorized by structure (product)\Benzimidazole-containing product\Acalabrutinib-containing product

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3642654010 Product containing acalabrutinib (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3712971015 Acalabrutinib-containing product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3642654010 Product containing acalabrutinib (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3642658013 Product containing acalabrutinib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3669400013 Acalabrutinib product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3712971015 Acalabrutinib-containing product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Acalabrutinib-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Acalabrutinib (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Acalabrutinib-containing product	Is a	Benzimidazole-containing product	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Acalabrutinib-containing product	Is a	Protein-tyrosine kinase inhibitor-containing product	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Acalabrutinib-containing product	Is a	Product containing non-specific protein-tyrosine kinase inhibitor (product)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Acalabrutinib-containing product	Plays role	Antineoplastic therapeutic role	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Acalabrutinib-containing product	Is a	agent antinéoplasique	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Acalabrutinib-containing product	Is a	Product containing enzyme inhibitor (product)	false	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Acalabrutinib-containing product in oral dose form	Is a	True	Acalabrutinib-containing product	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing only acalabrutinib (medicinal product)	Is a	True	Acalabrutinib-containing product	Inferred relationship	Existential restriction modifier (core metadata concept)

This concept is not in any reference sets